Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 233

Results For "drug"

3160 News Found

Covestro and PharmaJet work to take the sting out of vaccinations
Biotech | April 07, 2022

Covestro and PharmaJet work to take the sting out of vaccinations

Makrolon polycarbonate is key to needle-free injections that can stand up to sterilization


Lupin completes acquisition of brands from Anglo-French
Biotech | April 07, 2022

Lupin completes acquisition of brands from Anglo-French

The acquisition will strengthen Lupin’s India formulation business by adding a fast-growing portfolio of vitamins, minerals, supplements and neurological products


Indian pharma growth likely to moderate in FY23: ICRA
News | April 07, 2022

Indian pharma growth likely to moderate in FY23: ICRA

Headwinds related to pricing pressures and rising raw material costs will result in some contraction in margins in Q4 FY22 and FY23


CDMOs shifting focus to meet future demand
News | April 07, 2022

CDMOs shifting focus to meet future demand

An integrated and agile approach enables the pharmaceutical CDMO industry to simplify manufacturing as it moves from primary care medicines to specialty medicines


Gufic Biosciences receives DCGI approval for Thymosin Alpha-1 to treat Covid-19
Drug Approval | April 06, 2022

Gufic Biosciences receives DCGI approval for Thymosin Alpha-1 to treat Covid-19

Immunocin, an Immuno-modulator drug, significantly reduced the risk of death in the Phase 3 clinical trial in adult patients with moderate-to-severe Covid-19


MilliporeSigma acquires MAST platform from Lonza
Biotech | April 06, 2022

MilliporeSigma acquires MAST platform from Lonza

MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies


Singlera Genomics announces research collaboration with Astellas Pharma
Biotech | April 06, 2022

Singlera Genomics announces research collaboration with Astellas Pharma

The aim is to pursue methylation-based tools to better understand biological reactions to pharmaceuticals


AGC to invest $100 million for expanding synthetic pharmaceutical production in Spain
News | April 06, 2022

AGC to invest $100 million for expanding synthetic pharmaceutical production in Spain

The new facility is scheduled to start operation in the first half of 2024


Agilent joins AMBIC to advance biomanufacturing
Medical Device | April 05, 2022

Agilent joins AMBIC to advance biomanufacturing

Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives


Abott gets USFDA approval for leadless pacemaker
Drug Approval | April 05, 2022

Abott gets USFDA approval for leadless pacemaker

Aveir VR is specifically designed to be retrieved when therapy needs to evolve or the device needs to be replaced